Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease

Gill, Steven S., Patel, Nikunj K., Hotton, Gary R., O'Sullivan, Karen, McCarter, Renée, Bunnage, Martin, Brooks, David J., Svendsen, Clive N. +1 more·2003·Nature Medicine

DOI 10.1038/nm850

Cited by (1,000)

Items 301–400 of 1,000

Colocalization of Gadolinium-Diethylene Triamine Pentaacetic Acid With High-Molecular-Weight Molecules After Intracerebral Convection-Enhanced Delivery in Humans
John Howard Sampson, Martin Brady, Raghu Raghavan, Ankit Indravadan Mehta, Allan H. Friedman, David A. Reardon, Neil A. Petry, Daniel P. Barboriak, Terence Z. Wong, Michael R. Zalutsky et al. · 2011 · Neurosurgery
An Engineered Zinc Finger Protein Activator of the Endogenous Glial Cell Line-Derived Neurotrophic Factor Gene Provides Functional Neuroprotection in a Rat Model of Parkinson's Disease
Josée Laganière, Adrian P. Kells, Jeffrey T. Lai, Dmitry Y. Guschin, David E. Paschon, Xiangdong Meng, Lauren K. Fong, Qi Yu, Edward J. Rebar, Philip D. Gregory et al. · 2010 · Journal of Neuroscience
Ex vivo gene therapy for the treatment of neurological disorders
Genevíève Gowing, Soshana P. Svendsen, Clive N. Svendsen · 2017 · Progress in brain research
Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic?
Filippo Caraci, Giuseppe Battaglia, Maria Angela Sortino, Simona Federica Spampinato, Gemma Molinaro, Agata Copani, Ferdinando Nicoletti, Valeria Bruno · 2012 · Neurochemistry International
Quantitative1H Magnetic Resonance Spectroscopic Imaging Determines Therapeutic Immunization Efficacy in an Animal Model of Parkinson's Disease
Michael D. Boska, Travis B. Lewis, Christopher J. Destache, Eric J. Benner, Jay A. Nelson, Mariano Uberti, Rodney Lee Mosley, Howard Eliot Gendelman · 2005 · Journal of Neuroscience
Stem cell potential in Parkinson's disease and molecular factors for the generation of dopamine neurons
Hyun‐Jung Kim · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 2: Where do we stand and where must we go next?
Raymond T. Bartus, Eugene M. Johnson · 2016 · Neurobiology of Disease
Stem cells for Parkinson disease and ALS: replacement or protection?
Clive Niels Svendsen, J. William Langston · 2004 · Nature Medicine
Advancing neurotrophic factors as treatments for age-related neurodegenerative diseases: developing and demonstrating “clinical proof-of-concept” for AAV-neurturin (CERE-120) in Parkinson's disease
Raymond T. Bartus, Tiffany L. Baumann, Lamar Brown, Brian R. Kruegel, Jeffrey M. Ostrove, Christopher D. Herzog · 2012 · Neurobiology of Aging
Early transplantation of an encapsulated glial cell line—derived neurotrophic factor—producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease
Takao Yasuhara, Tetsuro Shingo, Kenichiro Muraoka, Kazuki Kobayashi, Akira Takeuchi, Akimasa Yano, Yuan Wenji, Masahiro Kameda, Toshihiro Matsui, Yasuyuki Miyoshi et al. · 2005 · Journal of neurosurgery
Retrograde transport of neurotrophic factor signaling: implications in neuronal development and pathogenesis
Keisuke Ito, Hideki Enomoto · 2016 · The Journal of Biochemistry
Experimental and Clinical Studies
Nondita Sarkar · 2005
Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases
Della Grace Thomas Parambi, Khalid Saad Alharbi, Rajesh Kumar, Seetha Harilal, Gaber El‐Saber Batiha, Natália Alves Martins, Omnia Magdy Hendawy, Arafa Musa, Dibya Sundar Panda, Bijo Mathew · 2021 · Molecular Neurobiology
Clinical neuroprotection in Parkinson's disease — Still waiting for the breakthrough
Matthias Löhle, Heinz Reichmann · 2009 · Journal of the Neurological Sciences
Focal treatment for refractory epilepsy: hope for the future?
Karen E. Nilsen, Hannah R. Cock · 2004 · Brain Research Reviews
The GDNF family members neurturin, artemin and persephin promote the morphological differentiation of cultured ventral mesencephalic dopaminergic neurons
Karin B. Zihlmann, Angélique Ducray, Benoît Schaller, Alexander W. Huber, Sandra H. Krebs, Robert H. Andres, Rolf Walter Seiler, Morten Meyer, Hans Ruedi Widmer · 2004 · Brain Research Bulletin
Mitochondria in neurodegenerative disorders: regulation of the redox state and death signaling leading to neuronal death and survival
Makoto Naoi, Wakako Maruyama, Hong Yi, Keiko Inaba, Yukihiro Akao, Masayo Shamoto‐Nagai · 2009 · Journal of Neural Transmission
Convective delivery of glial cell line–derived neurotrophic factor in the human putamen
Paul F. Morrison, Russell R. Lonser, Edward H. Oldfield · 2007 · Journal of neurosurgery
Gene therapy for neurological disorders
Chi‐Jing Choong, Kousuke Baba, Hideki Mochizuki · 2015 · Expert Opinion on Biological Therapy
Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson’s Disease
Amirah E.-E. Aly, Brendan T. Harmon, Linas Padegimas, Ozge Sesenoglu‐Laird, Mark J. Cooper, Barbara L. Waszczak · 2018 · Molecular Neurobiology
Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson’s disease
Makoto Naoi, Wakako Maruyama · 2009 · Expert Review of Neurotherapeutics
Trophic factors for Parkinson's disease: To live or let die
C. Warren Olanow, Raymond T. Bartus, Laura A. Volpicelli‐Daley, Jeffrey H. Kordower · 2015 · Movement Disorders
SINEUP Non-coding RNA Targeting GDNF Rescues Motor Deficits and Neurodegeneration in a Mouse Model of Parkinson’s Disease
Stefano Espinoza, Margherita Scarpato, Devid Damiani, Francesca Managò, Maddalena Mereu, Andrea Contestabile, Omar Peruzzo, Piero Carninci, Claudio Santoro, Francesco Papaleo et al. · 2019 · Molecular Therapy
Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases
Sureshbabu Ram Kumar Pandian, Kevin Kumar Vijayakumar, Sankaranarayanan Murugesan, Selvaraj Kunjiappan · 2022 · Heliyon
Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease
Xin Zheng, Deqiang Han, Weihua Liu, Xueyao Wang, Na Pan, Yuping Wang, Zhiguo Chen · 2023 · Theranostics
SorLA Controls Neurotrophic Activity by Sorting of GDNF and Its Receptors GFRα1 and RET
Simon Glerup, Maria Lume, Ditte Olsen, Jens Randel Nyengaard, Christian Bjerggaard Vægter, Camilla Gustafsen, Erik Christensen, Mads Kjølby, Anders Hay‐Schmidt, Dirk Bender et al. · 2013 · Cell Reports
Disease modification in Parkinson's disease
Anthony H.V. Schapira · 2004 · The Lancet Neurology
Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations
Wendy R. Galpern, Jacqueline Corrigan‐Curay, Anthony Edward Lang, Jeffrey P. Kahn, Danilo A. Tagle, Roger A. Barker, Thomas B Freeman, Christopher G. Goetz, Karl D. Kieburtz, Scott Y. H. Kim et al. · 2012 · The Lancet Neurology
Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies
Piotr Chmielarz, Märt Saarma · 2020 · Pharmacological Reports
Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions
Danielle Murray, A. Jon Stoessl · 2013 · Pharmacology & Therapeutics
Selective Glial Cell Line-Derived Neurotrophic Factor Production in Adult Dopaminergic Carotid Body CellsIn Situand after Intrastriatal Transplantation
Javier Villadiego, Simón Méndez‐Ferrer, Teresa Valdés‐Sánchez, Inmaculada Silos‐Santiago, Isabel Fariñas, José López‐Barneo, Juan José Toledo‐Aral · 2005 · Journal of Neuroscience
Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates
Dali Yin, Francisco E. Valles, Massimo S. Fiandaca, John Bringas, Francisco Gimenez, Mitchel Stuart Berger, John Forsayeth, Krystof S. Bankiewicz · 2009 · NeuroImage
THE DOPAMINERGIC NIGROSTRIATAL SYSTEMAND PARKINSON'S DISEASE
Mojgan Hodaie, Joseph Samir Neimat, Andrés M. Lozano · 2007 · Neurosurgery
Molecular landscape of long noncoding RNAs in brain disorders
Sumin Yang, Key‐Hwan Lim, Sung-Hyun Kim, Jae‐Yeol Joo · 2020 · Molecular Psychiatry
RET signaling does not modulate MPTP toxicity but is required for regeneration of dopaminergic axon terminals
Sebastian Kowsky, Charlotte Pöppelmeyer, Edgar R. Kramer, Björn H. Falkenburger, Anja Kruse, Rüdiger Klein, Jörg Bernhard Schulz · 2007 · Proceedings of the National Academy of Sciences
GDNF therapy for Parkinson’s disease
Murray G.L. Hong, Karim Mukhida, Ivar M. Mendez · 2008 · Expert Review of Neurotherapeutics
Motoneurons crave glial cell line-derived neurotrophic factor
Martha Churchill Bohn · 2004 · Experimental Neurology
Reversal of neurochemical changes and pain-related behavior in a model of neuropathic pain using modified lentiviral vectors expressing GDNF
Sophie Pezet, Agnieszka Krzyzanowska, Liang‐Fong Wong, John Grist, Nicholas D. Mazarakis, Biljana Georgievska, Stephen Brendan McMahon · 2006 · Molecular Therapy
Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys
Elisa Garbayo, Eduardo Ansorena, Hugo Lana, Mar Carmona‐Abellán, Irene Marcilla, José Luis Lanciego, M. R. Luquín, María J. Blanco‐Prieto · 2016 · Biomaterials
Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model
William Singleton, AM Collins, AS Bienemann, Clare L. Killick-Cole, Harry R. Haynes, Daniel J. Asby, Craig Philip Butts, MJ Wyatt, Neil U. Barua, SS Gill · 2017 · International Journal of Nanomedicine
Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease
Marchionini, Deanna M., Lehrmann, Elin, Chu, Yaping, He, Bin, Sortwell, Caryl E., Becker, Kevin G., Freed, William J., Kordower, Jeffrey H., Collier, Timothy J. · 2007 · Brain Research
Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats
Laura Grandoso, Sara Ponce Márquez, Iván Manuel, Aurora Arrúe, José Ángel Ruíz-Ortega, Isabel Ulibarri, Gorka Orive, Rosa Marı́a Hernández, A RODRIGUEZ, Rafael Rodríguez‐Puertas · 2007 · International Journal of Pharmaceutics
Stem cells as a potential treatment of neurological disorders
Yen Tai · 2003 · Current Opinion in Pharmacology
Glial cell line-derived neurotrophic factor-conjugated nanoparticles suppress acquisition of cocaine self-administration in rats
T. Green-Sadan, Y. Kuttner, Tammy Lublin‐Tennenbaum, Noa Kinor, Yonit Boguslavsky, Shlomo Margel, Gal Yadid · 2005 · Experimental Neurology
A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells
Niamh Moriarty, Carlos W. Gantner, Cameron J. Hunt, Charlotte M. Ermine, Stefano Frausin, Serena Viventi, Dmitry A. Ovchinnikov, Deniz Kirik, Clare L. Parish, Lachlan H. Thompson · 2022 · Cell stem cell
Recent developments in multifunctional neural probes for simultaneous neural recording and modulation
Hongbian Li, Jinfen Wang, Ying Ze Fang · 2023 · Microsystems & Nanoengineering
Granulocyte–macrophage colony‐stimulating factor promotes survival of dopaminergic neurons in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced murine Parkinson’s disease model
Na K. Kim, Byung Hyune Choi, Xian Huang, Brian Snyder, Shefqat Bukhari, TaeHo Kong, Hyeonseon Park, Hyung C. Park, So R. Park, Yoon Soo Ha · 2009 · European Journal of Neuroscience
Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease
Michael J. O’Neill, Tracey K. Murray, Katherine Whalley, Mark Ward, Caroline A. Hicks, Sandra Woodhouse, David J. Osborne, Phil Skolnick · 2004 · European Journal of Pharmacology
Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson’s disease
Biplob Dass, C. Olanow, J. Kordower · 2006 · Neurology
Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: Role of neuron–glia crosstalk
Ana Saavedra, Graça Baltazar, Paulo Rodrigues‐Santos, Caetana Monteiro Carvalho, Emı́lia P. Duarte · 2006 · Neurobiology of Disease
Neuroprotective therapy in Parkinson's disease and motor complications: A search for a pathogenesis-targeted, disease-modifying strategy
C. Warren Olanow, Joseph J. Jankovic · 2005 · Movement Disorders
The Pharmacology of Regenerative Medicine
George Joseph Christ, Justin M. Saul, Mark E. Furth, Karl‐Erik Andersson · 2013 · Pharmacological Reviews
Neurotrophic factor therapy for Parkinson′s disease: past, present and future
Aideen M. Sullivan, Gerard W. O’Keeffe · 2016 · Neural Regeneration Research
Minimally Invasive Nasal Depot (MIND) technique for direct BDNF AntagoNAT delivery to the brain
Smrithi Padmakumar, Gregory Jones, Grishma N. Pawar, Olga Khorkova, Jane H. Hsiao, Jonghan Kim, Mansoor M. Amiji, Benjamin Saul Bleier · 2021 · Journal of Controlled Release
Flexible microfluidic devices supported by biodegradable insertion scaffolds for convection-enhanced neural drug delivery
Conor P. Foley, Nozomi Nishimura, Keith B. Neeves, Chris B. Schaffer, William L. Olbricht · 2009 · Biomedical Microdevices
Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson's disease
Toru Yasuda, Momo Tani, Tomoko Nihira, Keiichiro Wada, Nobutaka Hattori, Yoshikuni Mizuno, Hideki Mochizuki · 2007 · Experimental Neurology
Neurotrophic Factors in Neurodegeneration
Armin Blesch · 2006 · Brain Pathology
Functional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease
Mara Brizard, Carole Carcenac, Alexis‐Pierre Bemelmans, Claude Feuerstein, Jacques J. Mallet, Marc Savasta · 2005 · Neurobiology of Disease
Benefits of putaminal GDNF infusion in Parkinson disease are maintained after GDNF cessation
Nikunj K. Patel, Nicola Pavese, Shazia Javed, Gary R. Hotton, David James Brooks, Steven S. Gill · 2013 · Neurology
A Clinical Approach Towards Smell Loss in Parkinson's Disease
Antje Haehner, Thomas R. Hummel, Heinz Reichmann · 2014 · Journal of Parkinson s Disease
Activation of mGlu3 Receptors Stimulates the Production of GDNF in Striatal Neurons
Giuseppe Battaglia, Gemma Molinaro, Barbara Riozzi, Marianna Storto, Carla Letizia Busceti, Paola Spinsanti, Domenico Bucci, Valentina Di Liberto, Giuseppa Mudò, Corrado Corti et al. · 2009 · PLoS ONE
Levodopa/dopamine replacement strategies in Parkinson's disease-Future directions
C. Warren Olanow · 2008 · Movement Disorders
Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease
K. Stahl, Maria N. Mylonakou, Øivind Skare, Mahmood Reza Amiry-Moghaddam, Reidun Torp · 2011 · Brain Research
A phase I trial of carboplatin administered by convection-enhanced delivery to patients with recurrent/progressive glioblastoma multiforme
Edward White, Alison S. Bienemann, Hannah Taylor, Kirsten Hopkins, Alison L. Cameron, Steven S. Gill · 2011 · Contemporary Clinical Trials
Differentiation and transcription factor gene therapy in experimental parkinson's disease: sonic hedgehog and gli-1, but not Nurr-1, protect nigrostriatal cell bodies from 6-OHDA-induced neurodegeneration
Andres Hurtado‐Lorenzo, E. Millan, Valeria Gonzalez‐Nicolini, D Suwelack, Maria Graciela Castro, Pedro Ricardo Lowenstein · 2004 · Molecular Therapy
Unilateral intraputaminal glial cell line–derived neurotrophic factor in patients with Parkinson disease: response to 1 year each of treatment and withdrawal
John T. Slevin, Don Marshall Gash, Charles D. Smith, Greg A. Gerhardt, Richard J. Kryscio, Himachandra Chebrolu, Ashley Walton, Renee P. Wagner, A. Byron Young · 2006 · Neurosurgical FOCUS
Autotransplantation of Bone Marrow-Derived Stem Cells as a Therapy for Neurodegenerative Diseases
I. Kan, Eldad Melamed, Daniel Offen · 2007 · Handbook of experimental pharmacology
Viral vectors as tools to model and treat neurodegenerative disorders
Nicole Déglon, Philippe Hantraye · 2005 · The Journal of Gene Medicine
Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson′s disease
Gerard W. O’Keeffe, Aideen M. Sullivan, Shane Vincent Hegarty · 2014 · Neural Regeneration Research
Drug delivery into the brain using poly(lactide-co-glycolide) microspheres
Philippe Meneï, Claudia N. Montero‐Menei, Marie‐Claire Venier‐Julienne, Jean‐Pierre Benoît · 2005 · Expert Opinion on Drug Delivery
Image-guided convection-enhanced delivery of GDNF protein into monkey putamen
Francisco Gimenez, Michal Tadeusz Krauze, Francisco E. Valles, Piotr Hadaczek, John Bringas, Nitasha Sharma, John Forsayeth, Krystof S. Bankiewicz · 2010 · NeuroImage
Potential Role of Growth Factors in the Management of Spinal Cord Injury
Basem Ibrahim Awad, Margaret A. Carmody, Michael P. Steinmetz · 2013 · World Neurosurgery
IGF-1 protects dopamine neurons against oxidative stress: association with changes in phosphokinases
Amina El Ayadi, Michael J. Zigmond, Amanda D. Smith · 2016 · Experimental Brain Research
Pharmacologically active microcarriers delivering BDNF within a hydrogel: Novel strategy for human bone marrow-derived stem cells neural/neuronal differentiation guidance and therapeutic secretome enhancement
Saikrishna Kandalam, Laurence Sindji, Gaëtan J.-R. Delcroix, Fabien Violet, Xavier Garric, Emilie M. André, Paul C. Schiller, Marie‐Claire Venier‐Julienne, Anne des Rieux, Jérôme Guicheux et al. · 2016 · Acta Biomaterialia
Stem cells may reshape the prospect of Parkinson's disease therapy
Kai‐Christian Sonntag, Rabi Simantov, Ole Isacson A · 2004 · Molecular Brain Research
Cellular repair of CNS disorders: an immunological perspective
Zhanfeng Chen, Theo D. Palmer · 2008 · Human Molecular Genetics
BMP2 and GDF5 induce neuronal differentiation through a Smad dependant pathway in a model of human midbrain dopaminergic neurons
Shane Vincent Hegarty, Aideen M. Sullivan, Gerard W. O’Keeffe · 2013 · Molecular and Cellular Neuroscience
Future and current surgical therapies in Parkinson's disease
Simone A. Betchen, Michael G. Kaplitt · 2003 · Current Opinion in Neurology
Stem Cell Transplantation: A Promising Therapy for Parkinson’s Disease
Yi Wang, Sheng Chen, Dehua Yang, Wei-Dong Le · 2007 · Journal of Neuroimmune Pharmacology
Therapeutic effects of repetitive transcranial magnetic stimulation in an animal model of Parkinson's disease
Ji Yong Lee, Sung Hoon Kim, Ah-Ra Ko, Jin Suk Lee, Ji Hea Yu, Jung Hwa Seo, Byung Pil Cho, Sung‐Rae Cho · 2013 · Brain Research
Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands
Deniz Kirik, Erik Ahlm Cederfjäll, Glenda Margaret Halliday, Åsa Petersén · 2016 · Neurobiology of Disease
Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects: implications for Parkinson's disease
Andrew Harkin, Eoin O′Neill · 2018 · Neural Regeneration Research
Progress in Target Drug Molecules for Alzheimer's Disease
Jiayang Xie, Ruirui Liang, Yan‐Jiang Wang, Junyi Huang, Xin Cao, Bing Niu · 2019 · Current Topics in Medicinal Chemistry
Effects of GDNF‐Loaded Injectable Gelatin‐Based Hydrogels on Endogenous Neural Progenitor Cell Migration
Deniece Fon, Aswan Al‐Abboodi, Peggy P. Y. Chan, Kun Zhou, Peter John Crack, David Isaac Finkelstein, John S. Forsythe · 2014 · Advanced Healthcare Materials
Interleukin-10 Protection against Lipopolysaccharide-Induced Neuro-Inflammation and Neurotoxicity in Ventral Mesencephalic Cultures
Yan Zhu, Xiao Chen, Zhan Liu, Yu-Ping Peng, Yihua Qiu · 2015 · International Journal of Molecular Sciences
Overexpression of glial cell line-derived neurotrophic factor induces genes regulating migration and differentiation of neuronal progenitor cells
Jens Pahnke, Eilhard Mix, Rupert Knoblich, Jana Annina Müller, Marlies Zschiesche, Beke Schubert, Dirk Koczan, Peter Bauer, Tobias Böttcher, Hans‐Jürgen Thiesen et al. · 2004 · Experimental Cell Research
Continuing trials of GDNF in Parkinson's disease
Roger A. Barker · 2006 · The Lancet Neurology
Clinical trials of neuroprotection for Parkinson’s disease
Peter A. LeWitt · 2004 · Neurology
Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor
Alan L. Whone, Kevin C. Kemp, Mingzhu Sun, Alastair Wilkins, Neil J. Scolding · 2011 · Brain Research
PEGylation improves the receptor-mediated transfection efficiency of peptide-targeted, self-assembling, anionic nanocomplexes
Aristides D. Tagalakis, Gavin D. Kenny, Alison S. Bienemann, David McCarthy, Mustafa M. Munye, Hannah Taylor, Marcella J. Wyatt, Mark F. Lythgoe, Edward A. White, Stephen L. Hart · 2013 · Journal of Controlled Release
Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD)
Muhammad Abid Sheikh, Yousra Saeed Malik, Zhenkai Xing, Zhaopei Guo, Huayu Tian, Xiaojuan Zhu, Xuesi Chen · 2016 · Acta Biomaterialia
Multifunctional receptor-targeted nanocomplexes for the delivery of therapeutic nucleic acids to the Brain
Gavin D. Kenny, Alison S. Bienemann, Aristides D. Tagalakis, John Pugh, Katharina Welser, Frederick Campbell, Alethea B. Tabor, Helen Claire Hailes, Steven Gill, Mark F. Lythgoe et al. · 2013 · Biomaterials
Treating Parkinson's disease in the 21st century: Can stem cell transplantation compete?
Philip C. Buttery, Roger A. Barker · 2014 · The Journal of Comparative Neurology
Neuroprotective Therapy in Parkinson Disease
Sheng Chen, Weidong Le · 2006 · American Journal of Therapeutics
Tetanus Toxin C-Fragment: The Courier and the Cure?
Janne M. Toivonen, Sara Oliván, Rosario Osta · 2010 · Toxins
Future of Cell and Gene Therapies for Parkinson’s Disease
O. Isacson, J. Kordower · 2008 · Annals of Neurology
AAV viral vector delivery to the brain by shape-conforming MR-guided infusions
Krystof S. Bankiewicz, Vivek R. Sudhakar, Lluı́s Samaranch, Waldy San Sebastián, John Bringas, John Forsayeth · 2016 · Journal of Controlled Release
TGF-β in Dopamine Neuron Development, Maintenance and Neuroprotection
Eleni Roussa, Oliver von Bohlen und Halbach, Kerstin G. KRIEGLSTEIN · 2009 · Advances in experimental medicine and biology
Levodopa-induced Dyskinesia in Parkinson’s disease: Epidemiology, etiology, and treatment
Theresa A. Zesiewicz, Kelly L. Sullivan, Robert A. Hauser · 2007 · Current Neurology and Neuroscience Reports
Biomarkers and focused ultrasound: the future of liquid biopsy for brain tumor patients
Jordina Rincón-Torroella, Harmon Singh Khela, Anya Bettegowda, Chetan Bettegowda · 2021 · Journal of Neuro-Oncology